Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP913210.RAUmRdgD4RzOvov74UtIqPSmCcI86l9FG9fdNstTZyryQ130_assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913210.RAUmRdgD4RzOvov74UtIqPSmCcI86l9FG9fdNstTZyryQ130_provenance.
• assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP521149.RAWNtqZ33hntPIkfwZ2itY4vbjljfG8dBoNGYZunBTtBA130_assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521149.RAWNtqZ33hntPIkfwZ2itY4vbjljfG8dBoNGYZunBTtBA130_provenance.
• NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP463101.RAXME41x4lpTC3UHHn0IKQT1r_YYKrgg4fVPlHERmWCto130_provenance.
• NP829172.RAGUXe_e93dpiqC74gvNoRwbSonAPOmbZTfxiZMfiq2lM130_assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829172.RAGUXe_e93dpiqC74gvNoRwbSonAPOmbZTfxiZMfiq2lM130_provenance.
• NP1383166.RAiDeFjcbkrCumJ0WrqRp70bbmH8bKP2Fp8m9XLRPRpA0130_assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383166.RAiDeFjcbkrCumJ0WrqRp70bbmH8bKP2Fp8m9XLRPRpA0130_provenance.
• NP1383169.RAnxYKG98Q8pQ7S8z1ABfJMhHl76ax3MZ1gzxYtau7l7I130_assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383169.RAnxYKG98Q8pQ7S8z1ABfJMhHl76ax3MZ1gzxYtau7l7I130_provenance.
• NP463098.RA4P2AKjULIdqBxF0--vr79nNQ0w6RR2WYaxqaeHPbwSE130_assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP463098.RA4P2AKjULIdqBxF0--vr79nNQ0w6RR2WYaxqaeHPbwSE130_provenance.
• NP463103.RAKyaviiyGqV5vLeA_GJLeuhGBjF1nmU8Fp592UFSMEnI130_assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP463103.RAKyaviiyGqV5vLeA_GJLeuhGBjF1nmU8Fp592UFSMEnI130_provenance.
• NP1383165.RAOnv4nEWRfuqCpDFs_Do_suE1fHKrxjNkjl3P87SpFZ8130_assertion description "[In contrast, HOXC5 expression was found in only 26 of 87 NHLs and appeared to be preferentially expressed by two specific subsets of lymphomas, ie, primary cutaneous anaplastic T-cell lymphomas (9 of 9) and extranodal marginal zone B-cell lymphomas (maltomas; 7 of 9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383165.RAOnv4nEWRfuqCpDFs_Do_suE1fHKrxjNkjl3P87SpFZ8130_provenance.